Chong Jin Kim Selected Research

Chong Jin Kim Research Topics

Disease

74	Myocardial Infarction 11/2021 - 03/2008
42	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 03/2008
33	ST Elevation Myocardial Infarction 03/2020 - 09/2008
18	Death (Near-Death Experience) 11/2021 - 05/2009
16	Thrombosis (Thrombus) 10/2021 - 03/2008
12	Non-ST Elevated Myocardial Infarction 03/2019 - 09/2008
10	Hemorrhage 03/2022 - 05/2009
6	Cardiogenic Shock 03/2020 - 01/2013
5	Heart Failure 11/2021 - 11/2010
4	Left Ventricular Dysfunction 11/2021 - 06/2010
4	Coronary Artery Disease (Coronary Atherosclerosis) 11/2015 - 12/2011
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2015 - 01/2011
4	Chronic Renal Insufficiency 10/2014 - 12/2012
3	Pathologic Constriction (Stenosis) 10/2021 - 01/2013
3	Type 2 Diabetes Mellitus (MODY) 09/2021 - 08/2014
3	Acute Coronary Syndrome 01/2020 - 11/2010
3	Infarction (Infarctions) 12/2019 - 04/2011
3	Heart Arrest (Cardiac Arrest) 11/2019 - 07/2014
3	Hypertension (High Blood Pressure) 03/2019 - 04/2011
3	Renal Insufficiency (Renal Failure) 05/2013 - 10/2011
2	Ischemic Stroke 02/2020 - 01/2020
2	Diabetes Mellitus 01/2018 - 05/2012
2	Inflammation (Inflammations) 05/2013 - 03/2012
2	Overweight 03/2012 - 11/2010
1	Rupture 02/2021
1	Atherosclerotic Plaque (Atheroma) 01/2021
1	AIDS-Related Complex (ARC) 01/2021
1	Hypertriglyceridemia 01/2021
1	Hemorrhagic Stroke 09/2019
1	Stroke (Strokes) 03/2019
1	Chest Pain (Chest Pains) 01/2019
1	Tachycardia (Tachyarrhythmias) 01/2019
1	MINOCA 01/2019
1	Hyperglycemia 01/2019
1	Spasm (Spasms) 01/2016
1	Coronary Disease (Coronary Heart Disease) 05/2015
1	Mitral Valve Insufficiency (Mitral Regurgitation) 10/2013
1	No-Reflow Phenomenon 01/2013
1	Atherosclerosis 03/2012

Drug/Important Bio-Agent (IBA)

37	omega-Chloroacetophenone (Mace)IBA 11/2021 - 03/2008
16	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 06/2010
9	zotarolimusIBA 01/2019 - 03/2010
8	Clopidogrel (Plavix)FDA Link 03/2022 - 02/2011
8	Everolimus FDA Link 01/2020 - 09/2012
6	LDL CholesterolIBA 01/2021 - 10/2010
5	CreatinineIBA 03/2020 - 06/2010
5	Sirolimus (Rapamycin)FDA Link 10/2014 - 03/2010
4	Glycoproteins (Glycoprotein)IBA 10/2016 - 01/2012
4	Paclitaxel (Taxol)FDA LinkGeneric 10/2014 - 01/2011
4	C-Reactive ProteinIBA 01/2014 - 04/2011
3	Pharmaceutical PreparationsIBA 02/2020 - 12/2014
3	oxidized low density lipoproteinIBA 09/2019 - 10/2011
3	TicagrelorIBA 03/2019 - 11/2018
3	HDL CholesterolIBA 05/2016 - 07/2014
3	Glucose (Dextrose)FDA LinkGeneric 11/2015 - 07/2014
3	MetalsIBA 12/2014 - 04/2011
3	Angiotensin Receptor AntagonistsIBA 12/2014 - 06/2010
3	CholesterolIBA 10/2010 - 06/2010
2	LipidsIBA 10/2021 - 01/2021
2	Atorvastatin (Lipitor)FDA Link 01/2021 - 01/2018
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2020 - 09/2012
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 02/2020 - 01/2020
2	LDL Lipoproteins (beta Lipoproteins)IBA 09/2019 - 10/2010
2	Prasugrel Hydrochloride FDA Link 03/2019 - 01/2019
2	Heparin (Liquaemin)FDA LinkGeneric 10/2016 - 04/2010
2	Angiotensin II Type 1 Receptor BlockersIBA 03/2016 - 01/2014
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2012 - 06/2010
2	Platelet Membrane Glycoprotein IIbIBA 05/2012 - 01/2012
2	pro-brain natriuretic peptide (1-76)IBA 04/2011 - 11/2010
2	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2011 - 11/2010
1	Antihypertensive Agents (Antihypertensives)IBA 09/2021
1	CatecholaminesIBA 02/2021
1	CalciumIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	PolymersIBA 01/2020
1	pitavastatin (itavastatin)FDA Link 01/2018
1	Simvastatin (Zocor)FDA LinkGeneric 12/2016
1	Ezetimibe (Zetia)FDA Link 12/2016
1	TroponinIBA 10/2016
1	NitratesIBA 10/2016
1	boldenone undecylenate (Equipoise)IBA 01/2016
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2015
1	Hemoglobins (Hemoglobin)IBA 08/2014
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2012
1	Abciximab (ReoPro)FDA Link 01/2012
1	Biomarkers (Surrogate Marker)IBA 07/2011
1	MB Form Creatine KinaseIBA 04/2011

Therapy/Procedure

54	Percutaneous Coronary Intervention 03/2020 - 03/2008
22	Stents 02/2020 - 03/2008
19	Therapeutics 11/2021 - 06/2009
17	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2018 - 05/2009
16	Drug-Eluting Stents 01/2020 - 03/2008
2	Length of Stay 10/2016 - 11/2008
1	Drug Therapy (Chemotherapy) 10/2020
1	Time-to-Treatment 01/2017
1	Cardiopulmonary Resuscitation (CPR) 01/2016
1	Secondary Prevention 02/2013
1	Artificial Respiration (Mechanical Ventilation) 01/2013
1	Dual Anti-Platelet Therapy 01/2013